Group 2 pulmonary hypertension
Clinical trials for Group 2 pulmonary hypertension explained in plain language.
Never miss a new study
Get alerted when new Group 2 pulmonary hypertension trials appear
Sign up with your email to follow new studies for Group 2 pulmonary hypertension, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ultrasound zaps lung nerves to ease heart failure symptoms
Disease control By invitation onlyThis early study is testing a device that uses ultrasound to ablate (calm) nerves in the pulmonary artery. The goal is to see if this procedure can improve quality of life for 50 people with heart failure and a specific type of pulmonary hypertension (Group 2). Participants will …
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Heart failure drug study pulled before it even started
Disease control CancelledThis study was designed to test the safety and tolerability of a new drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll about 20 to 30 adults aged 18 to 85. However, the study was withdrawn before any partic…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase 2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC